Laura Varona de Paus

Laura Varona de Paus

Auto-generated profile, based on publicly available information

Laura Varona de Paus

Molecular Physiology Leiden University Einsteinweg 55 Leiden The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
XLXiaoting Li
Xiaoting Li
HCHao Chang
Hao Chang
JBJara Bouma
Jara Bouma
LPLaura V. de Paus
Laura V. de Paus
PMPartha Mukhopadhyay
Partha Mukhopadhyay
THTian Hua
Tian Hua
Cannabinoid CB2 receptor (CB2R) agonists are investigated as therapeutic agents in the clinic. However, their molecular mode-of-action is not fully understood. Here, we report the discovery of LEI-102, a CB2R agonist, used in conjunction with three other CBR ligands (APD371, HU308, and CP55,940) to investigate the selective CB2R activation by binding kinetics, site-directed mutagenesis, and cryo-EM studies. We identify key residues for CB2R activation. Highly lipophilic HU308 and the endocannabinoids, but not the more polar LEI-102, APD371, and CP55,940, reach the binding pocket through a membrane channel in TM1-TM7. Favorable physico-chemical properties of LEI-102 enable oral efficacy in a chemotherapy-induced nephropathy model. This study delineates the molecular mechanism of CB2R activation by selective agonists and highlights the role of lipophilicity in CB2R engagement. This may have implications for GPCR drug design and sheds light on their activation by endogenous ligands.

1 March 2024 in ChemBioChem
Verified
Journal Article
Open access
LPLaura V. De Paus
Laura V. De Paus
YAYu An
Yu An
AJAntonius P. A. Janssen
Antonius P. A. Janssen
RBRichard J. B. H. N. van Den Berg
Richard J. B. H. N. van Den Berg
LHLaura Heitman
Laura Heitman
MSMario van der Stelt
Mario van der Stelt
The cannabinoid receptor type 2 (CB2R) is a G protein‐coupled receptor with therapeutic potential for the treatment of inflammatory disorders. Fluorescent probes are desirable to study its receptor localization, expression and occupancy. Previously, we have reported a photoaffinity probe LEI‐121 that stabilized the inactive conformation of the CB2R. Here, we report the structure‐based design of a novel bifunctional probe that captures the active conformation of the CB2R upon irradiation with light. An alkyne handle was incorporated to visualize the receptor using click‐chemistry with fluorophore‐azides. These probes may hold promise to study different receptor conformations in relation to their cellular localization and function.

14 December 2023 in Synlett
Verified
Journal Article
Open access
PDF file
LPLaura Varona de Paus
Laura Varona de Paus
MSMario van der Stelt
Mario van der Stelt
AJAntonius P.A. Janssen
Antonius P.A. Janssen
AHAsadullah Halimi
Asadullah Halimi
RBRichard J. B. H. N. van Den Berg
Richard J. B. H. N. van Den Berg
LHLaura H. Heitman
Laura H. Heitman
Cannabinoid receptor type 2 (CB2R) agonists have therapeutic potential for the treatment of (neuro)inflammatory diseases. Fluorescent probes enable the detection of CB2R in relevant cell types and serve as a chemical tool in cellular target engagement studies. Here, we report the structure-based design and synthesis of a new CB2R selective fluorescent probe. Based on the cryo-EM structure of LEI-102 in complex with the CB2R, we synthesized 5-fluoropyridin-2-yl-benzyl-imidazolidine-2,4-dione analogues in which we introduced a variety of linkers and fluorophores. Molecular pharmacological characterization showed that compound 22 containing a Cy5-fluorophore with an alkyl-spacer was the most potent probe with a pKi of 6.2 ± 0.6. It was selective over the cannabinoid CB1 receptor and behaved as an inverse agonist (EC50 5.3 ± 0.1, Emax -63% ± 6). Probe 22 may serve as a chemical tool in target and lead validation studies for the CB2R. Received: 08 November 2023 Accepted after revision: 14 December 2023 Accepted Manuscript online: 14 December 2023 © . The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany